All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Host | Hinge | TM | ICD | Inquiry & Datasheet |
CARMA-W1855 | Anti-DLL-3 (Rovalpituzumab) ICD(CD147) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | IgG1 | CD147 | CD147 | |
CARMA-W1856 | Anti-DLL-3 (Rovalpituzumab) ICD(CD86+FcγRI) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | CD8 | CD8 | CD86+FcγRI | |
CARMA-W1857 | Anti-DLL-3 (Rovalpituzumab) ICD(CD3ζ) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | CD8 | CD8 | CD3ζ | |
CARMA-W1858 | Anti-DLL-3 (Rovalpituzumab) ICD(Megf10) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | CD8 | CD8 | Megf10 | |
CARMA-W1859 | Anti-DLL-3 (Rovalpituzumab) ICD(FcRɣ) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | CD8 | CD8 | FcRɣ | |
CARMA-W1860 | Anti-DLL-3 (Rovalpituzumab) ICD(FcRɣ+PI3K) CAR-MA Plasmid, pCDCAR1 | Human | Rovalpituzumab | Humanized | CD8 | CD8 | FcRɣ+PI3K | |
CARMA-W1861 | Anti-DLL-3 (huSC16.13) ICD(CD147) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | IgG1 | CD147 | CD147 | |
CARMA-W1862 | Anti-DLL-3 (huSC16.13) ICD(CD86+FcγRI) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | CD8 | CD8 | CD86+FcγRI | |
CARMA-W1863 | Anti-DLL-3 (huSC16.13) ICD(CD3ζ) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | CD8 | CD8 | CD3ζ | |
CARMA-W1864 | Anti-DLL-3 (huSC16.13) ICD(Megf10) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | CD8 | CD8 | Megf10 | |
CARMA-W1865 | Anti-DLL-3 (huSC16.13) ICD(FcRɣ) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | CD8 | CD8 | FcRɣ | |
CARMA-W1866 | Anti-DLL-3 (huSC16.13) ICD(FcRɣ+PI3K) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.13 | Humanized | CD8 | CD8 | FcRɣ+PI3K | |
CARMA-W1869 | Anti-DLL-3 (huSC16.56) ICD(CD3ζ) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.56 | Humanized | CD8 | CD8 | CD3ζ | |
CARMA-W1870 | Anti-DLL-3 (huSC16.56) ICD(Megf10) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.56 | Humanized | CD8 | CD8 | Megf10 | |
CARMA-W1871 | Anti-DLL-3 (huSC16.56) ICD(FcRɣ) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.56 | Humanized | CD8 | CD8 | FcRɣ | |
CARMA-W1872 | Anti-DLL-3 (huSC16.56) ICD(FcRɣ+PI3K) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.56 | Humanized | CD8 | CD8 | FcRɣ+PI3K | |
CARMA-W1873 | Anti-DLL-3 (huSC16.34) ICD(CD147) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.34 | Humanized | IgG1 | CD147 | CD147 | |
CARMA-W1874 | Anti-DLL-3 (huSC16.34) ICD(CD86+FcγRI) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.34 | Humanized | CD8 | CD8 | CD86+FcγRI | |
CARMA-W1875 | Anti-DLL-3 (huSC16.34) ICD(CD3ζ) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.34 | Humanized | CD8 | CD8 | CD3ζ | |
CARMA-W1876 | Anti-DLL-3 (huSC16.34) ICD(Megf10) CAR-MA Plasmid, pCDCAR1 | Human | huSC16.34 | Humanized | CD8 | CD8 | Megf10 |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION